Publisher
Springer International Publishing
Reference34 articles.
1. Aarskog D. Clinical and cytogenetic studies in hypospadias. Acta Paediatr Scand. 1970;203(Suppl. 203):1–62. J Obstet Gynaecol. 1989;29:176–179.
2. Al-Suleiman SA, Najashi S, Rahman J, Rahman MS. Outcome of treatment with bromocriptine in patients with hyperprolactinemia. Aust N Z J Obstet Gynecol. 1989;29:176–9.
3. Asch RH, Greenblatt RB. Update on the safety and efficiency of clomiphene citrate as a therapeutic agent. J Reprod Med. 1976;17:175–80.
4. Benedum CN, Yazdy MM, Parker RE, Mitchell AA, Werler MM. Associations of clomiphene and assisted technologies with the risk of neural tube defects. Am J Epidemiol. 2016;183:977–87.
5. Bernard N, Elefant E, Carlier P, Tebacher M, Barjhoux CE, Bos-Thompson MA, Amar E, Descotes J, Vial T. Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study. BJOG. 2013;120:568–75.